相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment
Leide Caroline dos Santos Picanco et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons
Bonnie J. Berry et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Saak V. Ovsepian et al.
ALZHEIMERS & DEMENTIA (2018)
Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function
Kaichuan Zhu et al.
BIOLOGICAL PSYCHIATRY (2018)
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging
Carlo Condello et al.
BIOLOGICAL PSYCHIATRY (2018)
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
Kaichuan Zhu et al.
BIOLOGICAL PSYCHIATRY (2018)
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
Devendra Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
Xiangyou Hu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Click Chemistry-mediated Biotinylation Reveals a Function for the Protease BACE1 in Modulating the Neuronal Surface Glycoproteome
Julia Herber et al.
MOLECULAR & CELLULAR PROTEOMICS (2018)
BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice
WonHee Kim et al.
MOLECULAR NEURODEGENERATION (2018)
Reactive astrocytes in Alzheimer's disease: A double-edged sword
Heejung Chun et al.
NEUROSCIENCE RESEARCH (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains
Mirsada Causevic et al.
PLOS ONE (2018)
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Judite R. M. Coimbra et al.
FRONTIERS IN CHEMISTRY (2018)
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Ulf Neumann et al.
EMBO MOLECULAR MEDICINE (2018)
Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study
Maarten Timmers et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
Justyna A. Dobrowolska Zakaria et al.
EMBO MOLECULAR MEDICINE (2018)
Clinical Bioavailability of the Novel BACE1 Inhibitor Lanabecestat (AZD3293): Assessment of Tablet Formulations Versus an Oral Solution and the Impact of Gastric pH on Pharmacokinetics
Naidong Ye et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease
Gvido Cebers et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons
Ravi Rajmohan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A Peptides
Kei Sakamoto et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins
Tien-Phat V. Huynh et al.
JOURNAL OF LIPID RESEARCH (2017)
BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis
Shuting Zhang et al.
JOURNAL OF NEUROSCIENCE (2017)
Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice
Anna K. Engstrom et al.
MOLECULAR NEURODEGENERATION (2017)
The release and trans-synaptic transmission of Tau via exosomes
Yipeng Wang et al.
MOLECULAR NEURODEGENERATION (2017)
Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk
Anastasia G. Efthymiou et al.
MOLECULAR NEURODEGENERATION (2017)
Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A
Katarina Willen et al.
MOLECULAR NEURODEGENERATION (2017)
Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain
Michal Arbel-Ornath et al.
MOLECULAR NEURODEGENERATION (2017)
BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer's Disease Pathology
Gerald Koelsch
MOLECULES (2017)
Alzheimer's Disease-Related Dementias Summit 2016: National research priorities
Roderick A. Corriveau et al.
NEUROLOGY (2017)
Diagnostic impact of [18F] flutemetamol PET in early-onset dementia
Marissa D. Zwan et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
The role of astrocytes in amyloid production and Alzheimer's disease
Georgia R. Frost et al.
OPEN BIOLOGY (2017)
Role of BACE1 in Alzheimer's synaptic function
Brati Das et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Design, synthesis, and X-ray structural studies of BACE-1 inhibitors containing substituted 2-oxopiperazines as P1′-P2′ ligands
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling
Xiangyou Hu et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories
Pawel Tacik et al.
NEURODEGENERATIVE DISEASES (2016)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois et al.
ALZHEIMERS & DEMENTIA (2016)
RESULTS FROM A FIRST-IN-HUMAN STUDY WITH THE BACE INHIBITOR CNP520
Mike Ufer et al.
Alzheimers & Dementia (2016)
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia
Bryan D. James et al.
BRAIN (2016)
Physiological and pathological roles of the γ-secretase complex
Courtney M. Carroll et al.
BRAIN RESEARCH BULLETIN (2016)
Ion channel regulation by -secretase BACE1-enzymatic and non-enzymatic effects beyond Alzheimer's disease
Sandra Lehnert et al.
CHANNELS (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics
Susanna Eketjall et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease
Jack D. Scott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System
Kathryn M. Munro et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment
Peter Dongmin Sohn et al.
MOLECULAR NEURODEGENERATION (2016)
Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression
Mickael Audrain et al.
MOLECULAR NEURODEGENERATION (2016)
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease
Riqiang Yan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
Andrea M. Zuhl et al.
NATURE COMMUNICATIONS (2016)
Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
Derya R. Shimshek et al.
SCIENTIFIC REPORTS (2016)
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
Saoussen Ben Halima et al.
CELL REPORTS (2016)
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs
Riqiang Yan
TRANSLATIONAL NEURODEGENERATION (2016)
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies
Goran Simic et al.
BIOMOLECULES (2016)
Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
Severin Filser et al.
BIOLOGICAL PSYCHIATRY (2015)
Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice
Song Li et al.
SCIENTIFIC REPORTS (2015)
Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease
Martin R. Farlow et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
TDP-43 is a key player in the clinical features associated with Alzheimer's disease
Keith A. Josephs et al.
ACTA NEUROPATHOLOGICA (2014)
CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
Bruce Albala et al.
Alzheimers & Dementia (2014)
Lessons from a BACE1 inhibitor trial: Off-site but not off base
Debomoy K. Lahiri et al.
ALZHEIMERS & DEMENTIA (2014)
The evolution of amidine-based brain penetrant BACE1 inhibitors
Daniel Oehlrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Lessons from a Failed γ-Secretase Alzheimer Trial
Bart De Strooper
CELL (2014)
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease
Arun K. Ghosh et al.
CHEMICAL SOCIETY REVIEWS (2014)
Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction
Anna Mietelska-Porowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
β-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) Regulates Notch Signaling by Controlling the Cleavage of Jagged 1 (Jag1) and Jagged 2 (Jag2) Proteins
Wanxia He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
Janice A. Maloney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Riqiang Yan et al.
LANCET NEUROLOGY (2014)
BACE1 activity regulates cell surface contactin-2 levels
Vivek Gautam et al.
MOLECULAR NEURODEGENERATION (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
Lin Mei et al.
NEURON (2014)
Postsynaptic Target Specific Synaptic Dysfunctions in the CA3 Area of BACE1 Knockout Mice
Hui Wang et al.
PLOS ONE (2014)
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Robert Vassar
ALZHEIMERS RESEARCH & THERAPY (2014)
Comparative analysis of single and combined APP/APLP knockouts reveals reduced spine density in APP-KO mice that is prevented by APPsa expression
Sascha W. Weyer et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
The Alzheimer's β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
Patty C. Kandalepas et al.
ACTA NEUROPATHOLOGICA (2013)
Novel peptidomimetics as BACE-1 inhibitors: Synthesis, molecular modeling, and biological studies
Stefania Butini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story
Andrew Stamford et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Allosteric inhibition of BACE1 by an exosite-binding antibody
Weiru Wang et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2013)
BACE1 and presenilin/γ-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels
Carolyn C. Sachse et al.
FASEB JOURNAL (2013)
Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer's Disease
Jing Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Dual Cleavage of Neuregulin 1 Type III by BACE1 and ADAM17 Liberates Its EGF-Like Domain and Allows Paracrine Signaling
Daniel Fleck et al.
JOURNAL OF NEUROSCIENCE (2013)
Amyloid-β and APP Deficiencies Cause Severe Cerebrovascular Defects: Important Work for an Old Villain
Salvadore Luna et al.
PLOS ONE (2013)
BACE1 Regulates Hippocampal Astrogenesis via the Jagged1-Notch Pathway
Xiangyou Hu et al.
CELL REPORTS (2013)
Cross-sectional and Longitudinal Analysis of the Relationship Between Aβ Deposition, Cortical Thickness, and Memory in Cognitively Unimpaired Individuals and in Alzheimer Disease
Vincent Dore et al.
JAMA NEUROLOGY (2013)
Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
Paul J. Meakin et al.
BIOCHEMICAL JOURNAL (2012)
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
Peer-Hendrik Kuhn et al.
EMBO JOURNAL (2012)
ß-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment
Jun Cai et al.
EMBO MOLECULAR MEDICINE (2012)
Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase
De-Ming Chau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects
Brian Hitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The Neural Cell Adhesion Molecules L1 and CHL1 Are Cleaved by BACE1 Protease in Vivo
Lujia Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Developing ß-secretase inhibitors for treatment of Alzheimer's disease
Arun K. Ghosh et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Soluble A ss oligomer production and toxicity
Megan E. Larson et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
Guoxin Wu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Proteolytic Degradation of Amyloid β-Protein
Takaomi Saido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Processing of the Synaptic Cell Adhesion Molecule Neurexin-3β by Alzheimer Disease α- and γ-Secretases
Nathalie Bot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System
Mohamed H. Farah et al.
JOURNAL OF NEUROSCIENCE (2011)
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May et al.
JOURNAL OF NEUROSCIENCE (2011)
An update on the toxicity of Aβ in Alzheimer’s disease
Jurgen Gotz
Neuropsychiatric Disease and Treatment (2011)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Todd E. Golde et al.
EXPERIMENTAL NEUROLOGY (2010)
Amyloid-beta as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
The secretases: enzymes with therapeutic potential in Alzheimer disease
Bart De Strooper et al.
NATURE REVIEWS NEUROLOGY (2010)
Predicting memapsin 2 (β-secretase) hydrolytic activity
Xiaoman Li et al.
PROTEIN SCIENCE (2010)
Bridging Physiology and Pathology in AD
Dohoon Kim et al.
CELL (2009)
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Robert Vassar et al.
JOURNAL OF NEUROSCIENCE (2009)
Alzheimer's disease: synaptic dysfunction and Aβ
Ganesh M. Shankar et al.
MOLECULAR NEURODEGENERATION (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice
Kishore V. Kuchibhotla et al.
SCIENCE (2009)
Function, regulation and therapeutic properties of beta-secretase (BACE1)
Michael Willem et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Oxidative Stress Signaling in Alzheimer's Disease
B. Su et al.
CURRENT ALZHEIMER RESEARCH (2008)
BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus
Hui Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid Microglial Response Around Amyloid Pathology after Systemic Anti-Aβ Antibody Administration in PDAPP Mice
Jessica Koenigsknecht-Talboo et al.
JOURNAL OF NEUROSCIENCE (2008)
Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field:: Relationship with the progression of Alzheimer's disease
Afia Akram et al.
NEUROBIOLOGY OF AGING (2008)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Linking calcium to Aβ and Alzheimer's disease
Kim N. Green et al.
NEURON (2008)
β-secretase as a therapeutic target for Alzheimer's disease
Arun K. Ghosh et al.
NEUROTHERAPEUTICS (2008)
Sez-6 proteins affect dendritic arborization patterns and excitability of cortical pyramidal neurons
Jenny M. Gunnersen et al.
NEURON (2007)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
BACE1 regulates voltage-gated sodium channels and neuronal activity
Doo Yeon Kim et al.
NATURE CELL BIOLOGY (2007)
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Masuo Ohno et al.
NEUROBIOLOGY OF DISEASE (2007)
Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice
D Dominguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
β subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase
HK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (β-secretase)
RT Turner et al.
BIOCHEMISTRY (2005)
The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves α-, β-, γ-, and ε-like cleavages -: Modulation of APLP-1 processing by N-glycosylation
S Eggert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cleavage of amyloid-β precursor protein and amyloid-β precursor-like protein by BACE 1
QM Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease:: insight from transgenic mouse and tissue-culture models
J Götz et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2004)
BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time
Y Luo et al.
NEUROBIOLOGY OF DISEASE (2003)
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
PR Turner et al.
PROGRESS IN NEUROBIOLOGY (2003)
Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia
PM Stanford et al.
BRAIN (2003)
α-synuclein, Aβ and Alzheimer's disease
O Wirths et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease
T Bussiere et al.
NEUROSCIENCE (2003)
Study of memapsin 2 (beta-secretase) and strategy of inhibitor design
J Tang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
β-Secretase (BACE) as a drug target for alzheimer's disease
R Vassar
ADVANCED DRUG DELIVERY REVIEWS (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Subsite specificity of memapsin 2 (β-secretase):: Implications for inhibitor design
RT Turner et al.
BIOCHEMISTRY (2001)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
分享论文
